The RISC Registry--Risk Informed Screening Registry — RISC  

Breast Cancer Risk Clinical Trial

Official title: The Risk Informed Screening Registry (The RISC Registry)

Status Not yet recruiting

Clinical Trial Summary

Health inequities are defined as systemic differences in the health status of different population groups. It is well established that there are many sources of health inequity in oncology including differences in mortality, cancer screening uptake, time to diagnosis and disparities in access to treatment and care. Routine cancer screening and effective surveillance and follow up are some of the most effective ways to reduce the burden of cancer across an individual's lifetime and at the population level. While there is a lack of screening tests for many cancers, breast cancer, the second highest leading cause of cancer death in women, has a plethora of validated screening and risk reduction approaches which can yield earlier detection and effective ways of treating and following women at risk and with breast cancer and improve outcomes. However, there is uneven adoption and inconsistent use of these technologies and care practices. The RISC Registry is an observational study that seeks to understand the application of risk-informed screening and care approaches and pursue the hypothesis that these screening approaches accompanied by population appropriate methods of clinician and patient engagement may increase understanding and compliance with screening, surveillance and follow up recommendations by empowering people to make healthier choices, and support addressing disparities in screening and patient care. The primary focus is cancer screening with a focus on Precision Screening. (Precision Screening attempts to separate those who will benefit from screening from those that may not, through use of information on disease risk.) The study will start by focusing on women and breast cancer risk.

Clinical Trial Description

The RISC Registry (the "Registry" ) is a longitudinal observational database designed to capture health information to help develop individualized disease risk and care plans in varied patient populations and study how that information impacts physician recommendations and patient compliance. The Registry was designed by a board of Scientific Advisors who are active users of risk assessment tools, and risk-informed screening protocols, including physicians, nurses, and patient advocates. Technology professionals and site administrators were also consulted regarding optimizing the process of data collection and dissemination. The Registry uses widely accepted standards for risk and disease classifications, results, management, and validated quality-of-life measures. The Registry is vendor-agnostic and product-agnostic. This study will make a special effort to reach women who have historically been underserved by recruiting patients broadly distributed across different socioeconomic groups, ethnicities and diverse geographic areas. The RISC Registry will help determine the ongoing value of Precision Screening in different clinical patient populations, shape guidelines for screening and optimal patient management, and support improvements in Precision Health and Precision Medicine support technology. Eligible subjects will be offered personalized risk assessments and care plans at no charge to reduce cost as a barrier to screening. ;

Related Conditions & MeSH terms

• Breast Cancer Risk

• NCT number: NCT05848856
• Study type: Observational
• Source: Precision Health Equity Initiative
• Contact: Mary Kay Hardwick, MBA
• Phone: 5106826256
• Email: mk@phei.org
• Status: Not yet recruiting
• Start date: June 1, 2023
• Completion date: June 1, 2033